Literature DB >> 8883257

Successful management of a giant spinal arteriovenous malformation with multiple communications between primitive arterial and venous structures by embolization: report of a case.

T Kuga1, K Esato, N Zempo, K Fujioka, M Harada, A Furutani, N Akiyama, S Toyota, Y Fujita.   

Abstract

A 47-year-old woman was admitted to our hospital with a giant spinal arteriovenous malformation (AVM) causing heart failure and thoracic myelopathy. Angiography revealed that the spinal AVM had multiple feeding vessels branching from the 5th through 12th intercostal arteries. The drainage vein flowed to the azygos vein and superior vena cava. The AVM destroyed the 7th thoracic vertebra. The cardiac output was 16.7l/min and the shunt ratio was 64% before treatment. Embolization with cyanoacrylate was performed because the operation was considered to be associated with a significant risk of paraplegia and organ ischemia. The cardiac output decreased to 11.6l/min and the shunt ratio was reduced to 32%. After embolization the patient demonstrated no symptoms of either heart failure or sensory deficits. During embolization, provocative tests using sodium amytal and lidocaine with magnetic stimulation were also performed. The above findings suggest that provocative tests and magnetic stimulation are useful to predict paraplegia, which could result from embolization while, in addition, embolization is considered to be a useful treatment for multiple shunt and nidus in this region.

Entities:  

Mesh:

Year:  1996        PMID: 8883257     DOI: 10.1007/bf00312103

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Thoracic arteriovenous fistula: venous connection to right iliac vein.

Authors:  G F Atwood; T D King; T P Graham; R V Canent; P A Ebert; M S Spach
Journal:  Am J Dis Child       Date:  1975-02

2.  Arteriovenous fistula between descending aorta and hemiazygos vein.

Authors:  P G Gamba; M Longo; G F Zanon; M Guglielmi
Journal:  Eur J Pediatr Surg       Date:  1991-02       Impact factor: 2.191

3.  Embolization of spinal dural arteriovenous fistula with polyvinyl alcohol particles: experience in 14 patients.

Authors:  D A Nichols; D A Rufenacht; C R Jack; G S Forbes
Journal:  AJNR Am J Neuroradiol       Date:  1992 May-Jun       Impact factor: 3.825

4.  Chronic arteriovenous fistulas masquerading as arteriovenous malformations: diagnostic considerations and therapeutic implications.

Authors:  R B Lawdahl; W D Routh; J J Vitek; H A McDowell; G M Gross; F S Keller
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

5.  Lidocaine injection into external carotid branches: provocative test to preserve cranial nerve function in therapeutic embolization.

Authors:  J A Horton; C W Kerber
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

Review 6.  Arteriovenous malformations (AVM) of the spinal cord in children. A review of 38 cases.

Authors:  M C Riché; J Modenesi-Freitas; M Djindjian; J J Merland
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

7.  Aortic aneurysm producing back pain, bone destruction, and paraplegia.

Authors:  B M Rothschild; L Cohn; A Aviza; B H Yoon
Journal:  Clin Orthop Relat Res       Date:  1982-04       Impact factor: 4.176

8.  Balloon test occlusion of the internal carotid artery with stable xenon/CT cerebral blood flow imaging.

Authors:  S M Erba; J A Horton; R E Latchaw; H Yonas; L Sekhar; V Schramm; S Pentheny
Journal:  AJNR Am J Neuroradiol       Date:  1988 May-Jun       Impact factor: 3.825

9.  Successful surgical obliteration of a huge intradural arteriovenous fistula of the spinal cord in a child.

Authors:  S Wakai; S Inoh; H Iwanaga; M Nagai; T Sato; J Izumi
Journal:  Childs Nerv Syst       Date:  1992-09       Impact factor: 1.475

10.  Congenital systemic arteriovenous fistula between the descending aorta, azygos vein, and superior vena cava.

Authors:  P Soler; A V Mehta; O L Garcia; G Kaiser; D Tamer
Journal:  Chest       Date:  1981-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.